Since last year, JAT had stated that margins will be tight till they start to manufacture
Hence the 3 stage approach - so far they have been on track
I do agree with @csfoo7211 that there are trade receivables that have not been mention in this quarterly
Look at Dec Q, there were $4.8million receivables not mention in Q (Refer to Half yearly report)
If you add up the trade receivables $4.8million with March revenue $8 million. That would leave $7.7 million generated from Jan and Feb - due to CNY celebrations, sales had been down and now they are picking up
Given the new products and distribution deals, this upcoming Q will be significant in terms of revenue
In regards to the options, unclear if they expire in June 2019 or Nov 2019. Adds further cash to the kitty.
These are great buying price...
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
Since last year, JAT had stated that margins will be tight till...
-
- There are more pages in this discussion • 120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.46M |
Open | High | Low | Value | Volume |
45.0¢ | 45.0¢ | 45.0¢ | $4.425K | 9.833K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 21502 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.0¢ | 33334 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 21502 | 0.450 |
1 | 50 | 0.425 |
3 | 22000 | 0.420 |
2 | 21300 | 0.410 |
4 | 40750 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.540 | 33334 | 1 |
0.550 | 51242 | 2 |
0.560 | 12073 | 3 |
0.590 | 20000 | 1 |
0.595 | 20000 | 1 |
Last trade - 15.40pm 12/11/2024 (20 minute delay) ? |
Featured News
JAT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online